Is cabozantinib included in medical insurance? How much?

Cabozantinib is an oral targeted therapy drug that is a multi-target tyrosine kinase inhibitor. It is mainly used to treat certain types of cancer, especially renal cell carcinoma (kidney cancer) and thyroid cancer. Cabozantinib, as a targeted drug, exerts anti-cancer effects by inhibiting the activity of multiple receptor kinases and interfering with the proliferation, angiogenesis and metastasis of tumor cells. Cabozantinib is not currently on the market in China and is therefore not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase it through overseas channels. There are original and generic drugs of cabozantinib abroad. The original drugs are mainly Japanese original drugs, Turkish original drugs and European version of original drugs. Foreign generic drugs are mainly Laos generic drugs and Bangladeshi generic drugs, with prices ranging from 1,300 to 2,700 yuan, and the ingredients of original drugs and generic drugs are basically the same.